PMC:7073332 / 23916-25262
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
703 | 120-126 | Gene | denotes | mTORC1 | Gene:382056 |
704 | 303-332 | Gene | denotes | mammalian target of rapamycin | Gene:2475 |
705 | 334-338 | Gene | denotes | mTOR | Gene:2475 |
706 | 1309-1315 | Gene | denotes | PABPC1 | Gene:26986 |
707 | 1317-1321 | Gene | denotes | NPM1 | Gene:4869 |
708 | 1327-1330 | Gene | denotes | NCL | Gene:4691 |
709 | 201-222 | Species | denotes | Andes orthohantavirus | Tax:1980456 |
710 | 227-238 | Species | denotes | coronavirus | Tax:11118 |
711 | 584-592 | Species | denotes | patients | Tax:9606 |
712 | 605-609 | Species | denotes | H1N1 | Tax:114727 |
713 | 668-676 | Species | denotes | patients | Tax:9606 |
714 | 1068-1076 | Species | denotes | SARS-CoV | Tax:694009 |
715 | 1081-1089 | Species | denotes | MERS-CoV | Tax:1335626 |
716 | 99-108 | Chemical | denotes | rapamycin | MESH:D020123 |
717 | 245-254 | Chemical | denotes | Sirolimus | MESH:D020123 |
718 | 270-274 | Chemical | denotes | GSEA | |
719 | 494-503 | Chemical | denotes | sirolimus | MESH:D020123 |
720 | 556-565 | Chemical | denotes | sirolimus | MESH:D020123 |
721 | 705-719 | Chemical | denotes | Mercaptopurine | MESH:D015122 |
722 | 735-739 | Chemical | denotes | GSEA | |
723 | 1002-1016 | Chemical | denotes | Mercaptopurine | MESH:D015122 |
724 | 1230-1244 | Chemical | denotes | mercaptopurine | MESH:D015122 |
725 | 512-530 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
726 | 610-619 | Disease | denotes | pneumonia | MESH:D011014 |
727 | 630-649 | Disease | denotes | respiratory failure | MESH:D012131 |
728 | 832-838 | Disease | denotes | cancer | MESH:D009369 |
729 | 927-947 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
730 | 949-977 | Disease | denotes | systemic lupus erythematosus | MESH:D008180 |
731 | 983-998 | Disease | denotes | Crohn’s disease | MESH:D003424 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T128 | 381-388 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T129 | 1277-1285 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T102 | 521-530 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T103 | 610-619 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T104 | 624-649 | Disease | denotes | acute respiratory failure | http://purl.obolibrary.org/obo/MONDO_0001208|http://purl.obolibrary.org/obo/MONDO_0021113 |
T106 | 832-838 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T107 | 895-915 | Disease | denotes | auto-immune diseases | http://purl.obolibrary.org/obo/MONDO_0007179 |
T108 | 927-947 | Disease | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/MONDO_0008383 |
T109 | 938-947 | Disease | denotes | arthritis | http://purl.obolibrary.org/obo/MONDO_0005578 |
T110 | 949-977 | Disease | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/MONDO_0007915 |
T111 | 958-977 | Disease | denotes | lupus erythematosus | http://purl.obolibrary.org/obo/MONDO_0004670 |
T112 | 1068-1076 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T188 | 168-175 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T189 | 809-812 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T190 | 1017-1020 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T191 | 1038-1039 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T265 | 21-42 | Chemical | denotes | antineoplastic agents | http://purl.obolibrary.org/obo/CHEBI_35610 |
T266 | 99-108 | Chemical | denotes | rapamycin | http://purl.obolibrary.org/obo/CHEBI_9168 |
T267 | 245-254 | Chemical | denotes | Sirolimus | http://purl.obolibrary.org/obo/CHEBI_9168 |
T268 | 290-299 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T269 | 323-332 | Chemical | denotes | rapamycin | http://purl.obolibrary.org/obo/CHEBI_9168 |
T270 | 381-388 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T271 | 481-492 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
T272 | 494-503 | Chemical | denotes | sirolimus | http://purl.obolibrary.org/obo/CHEBI_9168 |
T273 | 556-565 | Chemical | denotes | sirolimus | http://purl.obolibrary.org/obo/CHEBI_9168 |
T274 | 705-719 | Chemical | denotes | Mercaptopurine | http://purl.obolibrary.org/obo/CHEBI_50667 |
T275 | 755-775 | Chemical | denotes | antineoplastic agent | http://purl.obolibrary.org/obo/CHEBI_35610 |
T276 | 781-798 | Chemical | denotes | immunosuppressant | http://purl.obolibrary.org/obo/CHEBI_35705 |
T277 | 872-883 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
T278 | 1002-1016 | Chemical | denotes | Mercaptopurine | http://purl.obolibrary.org/obo/CHEBI_50667 |
T279 | 1050-1059 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T280 | 1184-1194 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T281 | 1230-1244 | Chemical | denotes | mercaptopurine | http://purl.obolibrary.org/obo/CHEBI_50667 |
T282 | 1277-1285 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 1149-1165 | http://purl.obolibrary.org/obo/GO_0019075 | denotes | viral maturation |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T12 | 610-619 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T13 | 630-649 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
T14 | 832-838 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T15 | 895-915 | Phenotype | denotes | auto-immune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
T16 | 927-947 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
T17 | 949-977 | Phenotype | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/HP_0002725 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T145 | 0-42 | Sentence | denotes | Immunosuppressant or antineoplastic agents |
T146 | 43-244 | Sentence | denotes | Previous studies have confirmed the mammalian target of rapamycin complex 1 (mTORC1) as the key factor in regulating various viruses’ replications, including Andes orthohantavirus and coronavirus48,49. |
T147 | 245-433 | Sentence | denotes | Sirolimus (Z = –2.35 and GSEA score = 3), an inhibitor of mammalian target of rapamycin (mTOR), was reported to effectively block viral protein expression and virion release effectively50. |
T148 | 434-545 | Sentence | denotes | Indeed, the latest study revealed the clinical application: sirolimus reduced MERS-CoV infection by over 60%51. |
T149 | 546-704 | Sentence | denotes | Moreover, sirolimus usage in managing patients with severe H1N1 pneumonia and acute respiratory failure can improve those patients’ prognosis significantly50. |
T150 | 705-1001 | Sentence | denotes | Mercaptopurine (Z = –2.44 and GSEA score = 1), an antineoplastic agent with immunosuppressant property, has been used to treat cancer since the 1950s and expanded its application to several auto-immune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and Crohn’s disease52. |
T151 | 1002-1212 | Sentence | denotes | Mercaptopurine has been reported as a selective inhibitor of both SARS-CoV and MERS-CoV by targeting papain-like protease which plays key roles in viral maturation and antagonism to interferon stimulation53,54. |
T152 | 1213-1346 | Sentence | denotes | Mechanistically, mercaptopurine potentially target several host proteins in HCoVs, such as JUN, PABPC1, NPM1, and NCL40,55 (Fig. 5d). |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32194980-23135723-19614197 | 238-240 | 23135723 | denotes | 48 |
32194980-26276683-19614198 | 241-243 | 26276683 | denotes | 49 |
32194980-24105455-19614199 | 430-432 | 24105455 | denotes | 50 |
32194980-29143192-19614200 | 542-544 | 29143192 | denotes | 51 |
32194980-24105455-19614201 | 701-703 | 24105455 | denotes | 50 |
32194980-18097462-19614202 | 998-1000 | 18097462 | denotes | 52 |
32194980-19374142-19614203 | 1206-1208 | 19374142 | denotes | 53 |
32194980-25542975-19614204 | 1209-1211 | 25542975 | denotes | 54 |
32194980-23637410-19614205 | 1330-1332 | 23637410 | denotes | 40 |
32194980-11967337-19614206 | 1333-1335 | 11967337 | denotes | 55 |